Navigation Links
Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institute's Samuel L. Pfaff, Ph.D. - to its International Research Consortium

Pfaff Brings Expertise in Motor Neuron Development to the Foundation's Efforts on Behalf of People living with Spinal Cord Injury

SHORT HILLS, N.J., Aug. 21 /PRNewswire-USNewswire/ -- The Christopher and Dana Reeve Foundation today announced it has expanded the work of its International Consortium on Spinal Cord Injury to include a focus on the study of stem cells in injury and repair. Samuel L. Pfaff, Ph.D., of The Salk Institute, who has demonstrated expertise in stem cell biology and spinal cord expertise, has joined the Consortium as a Principal Investigator. Additionally, the laboratory of Fred H. Gage, Ph.D., also at The Salk, will reorient more exclusively to stem cell research, with an emphasis on human embryonic stem cells. Dr. Gage will also oversee a stem cell core laboratory that will serve as infrastructure for the research network.

The Research Consortium on Spinal Cord Injury works to promote structural repair and functional recovery in the acutely and chronically injured spinal cord. Its scientists pursue this mission through collaborative research across eight international laboratories that focuses on optimizing the intrinsic capacity of the adult nervous system to repair and remodel itself and eliciting robust regenerative responses after injury.

"Dr. Pfaff's expertise in the embryonic development of the spinal cord will add significant value to our research enterprise," says Susan Howley, executive vice president for research at the Reeve Foundation. "The spinal cord is so complex that the role of stem cells in repair and regeneration has to be considered within the context of what we know about the uninjured and injured spinal cord. The Consortium is a perfect environment within which to do that."

The decision to deploy a stem cell initiative under the aegis of its Research Consortium was made by the Reeve Foundation as a result of a workshop of international stem-cell experts it sponsored last year. The Foundation asked the participants, scientists and clinicians, to make strategic recommendations about how to invest research dollars to move the field of injury repair and regeneration forward. Following submission of a workshop report to the Foundation, the Board's Research Planning Committee worked for several months to develop a stem cell initiative for consideration by the full Board of Directors. It was approved by the Board late last year.

At the Salk Institute in La Jolla, California, Dr. Pfaff heads the Gene Expression Laboratory. There, he focuses on the embryonic development of motor neurons--cells that transmit signals from the brain or spinal cord to muscles throughout the body to generate movement.

Specifically, the Pfaff lab has been focusing on several areas of investigation:

-- Stem cells and fate choices: How do stem cells "choose" from among a variety of fates and acquire their specific identities as motor neurons?

-- Axon guidance: How do motor axons -- the slender projections from nerve cells -- travel from the brain or spinal cord to their target destinations throughout the body?

-- Locomotor circuitry: How does the wiring process develop, and how is it orchestrated in such a way as to enable us to walk?

Dr. Pfaff and his colleagues have been seeking answers to these questions via mouse and human embryonic stem cell research. Further, they have been using mouse genetics to study the underpinnings of the neural network known as the central pattern generator (CPG), which generates the coordinated and rhythmic firing of motor neurons needed for walking.

Dr. Pfaff has a long history with the Reeve Foundation, as a member of its Science Advisory Council, which oversees the Individual Grants Program. He received his Ph.D. from UC Berkeley and conducted postdoctoral study at Vanderbilt University and Columbia University. He has received a McKnight Scholar Award in Neurobiology, a March of Dimes Basil O'Connor Scholar Award, and an Alfred P. Sloan Research Fellow Award. Recently named a Howard Hughes Medical Institute (HHMI) investigator, Dr. Pfaff is a strong proponent of cross-disciplinary collaboration in research, an approach shared by the Reeve Foundation.

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research and to improving the quality of life for people living with paralysis through grants, information and advocacy. For more information on the Reeve Foundation's International Research Consortium on Spinal Cord Injury and its eight laboratories, visit

SOURCE The Christopher and Dana Reeve Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Christopher and Dana Reeve Foundation Lauds U.S. House of Representatives Passage of the Christopher and Dana Reeve Paralysis Act
2. COLORBLENDS to Donate Portion of Sales of Spring Forward Daffodil Blend to the Christopher and Dana Reeve Foundation
3. Christopher Reeve Honored as Heroes Hero By CNN
4. Matthew Reeve to Host The Christopher and Dana Reeve Foundations Annual Hamptons Summer Soiree
5. National Patient Safety Foundation Partners with Vocera Communications
6. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
7. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
8. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
9. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
10. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
11. The Tug McGraw Foundation Announces 2007 Fundraising Gala
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: